{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:22:26Z","timestamp":1792264946310,"version":"4.4.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biomaterials.2022.121762","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T23:31:28Z","timestamp":1661470288000},"page":"121762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Image-guided in situ cancer vaccination with combination of multi-functional nano-adjuvant and an irreversible electroporation technique"],"prefix":"10.1016","volume":"289","author":[{"given":"Jun-Hyeok","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0266-0040","authenticated-orcid":false,"given":"Ha Eun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeon Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Pin","family":"James Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2917-2274","authenticated-orcid":false,"given":"Jong-Hwi","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3175-0376","authenticated-orcid":false,"given":"Ho-Keun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3979-5405","authenticated-orcid":false,"given":"Tae-Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6300-9377","authenticated-orcid":false,"given":"Young Bin","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-3319","authenticated-orcid":false,"given":"Dong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Gwon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4641-7883","authenticated-orcid":false,"given":"Dong Keun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-0530","authenticated-orcid":false,"given":"Wooram","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7378","key":"10.1016\/j.biomaterials.2022.121762_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"issue":"6382","key":"10.1016\/j.biomaterials.2022.121762_bib2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"6230","key":"10.1016\/j.biomaterials.2022.121762_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"issue":"6230","key":"10.1016\/j.biomaterials.2022.121762_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"issue":"25","key":"10.1016\/j.biomaterials.2022.121762_bib5","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121762_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.biomaterials.2022.121762_bib8","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2022.121762_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2022.121762_bib10","series-title":"Survival, Response Duration, and Activity by BRAF Mutation (MT) Status of Nivolumab (NIVO, Anti-PD-1, BMS-936558, ONO-4538) and Ipilimumab (IPI) Concurrent Therapy in Advanced Melanoma (MEL)","author":"Sznol","year":"2014"},{"key":"10.1016\/j.biomaterials.2022.121762_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2017.05.011","article-title":"Delivering safer immunotherapies for cancer","volume":"114","author":"Milling","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121762_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving cancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121762_bib13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41591-019-0410-x","article-title":"Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination","volume":"25","author":"Hammerich","year":"2019","journal-title":"Nat. Med."},{"issue":"305","key":"10.1016\/j.biomaterials.2022.121762_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole body irradiation\u2014radiobiology or medicine?","volume":"26","author":"Mole","year":"1953","journal-title":"Br. J. Radiol."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121762_bib15","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1172\/JCI64859","article-title":"Depleting tumor-specific Tregs at a single site eradicates disseminated tumors","volume":"123","author":"Marabelle","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"226","key":"10.1016\/j.biomaterials.2022.121762_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008095","article-title":"Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy","volume":"6","author":"Zamarin","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121762_bib17","first-page":"2950","article-title":"Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cells","volume":"9","author":"Van Herpen","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cncr.10631","article-title":"Phase I trial of subcutaneous recombinant human interleukin\u20102 in patients with metastatic melanoma","volume":"95","author":"Eton","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121762_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0277-5379(89)90034-5","article-title":"Phase I study of intratumoral application of recombinant human tumor necrosis factor","volume":"25","author":"Pfreundschuh","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121762_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121762_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121762_bib22","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/0008-5472.CAN-12-3343","article-title":"Localized immunotherapy via liposome-anchored Anti-CD137+ IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity","volume":"73","author":"Kwong","year":"2013","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121762_bib23","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.081626898","article-title":"Role of tumor\u2013host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors","volume":"98","author":"Pluen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121762_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2020192190","article-title":"High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy","volume":"295","author":"Geboers","year":"2020","journal-title":"Radiol"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121762_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/bioe.2019.0029","article-title":"Irreversible electroporation: background, theory, and review of recent developments in clinical oncology","volume":"1","author":"Aycock","year":"2019","journal-title":"Bioelectricity"},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121762_bib26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jvir.2014.01.028","article-title":"Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy","volume":"25","author":"Scheffer","year":"2014","journal-title":"J. Vasc. Intervent. Radiol."},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121762_bib27","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3390\/cancers12113123","article-title":"Combination of irreversible electroporation and sting agonist for effective cancer immunotherapy","volume":"12","author":"Go","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib28","first-page":"1","article-title":"Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2022.121762_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jiec.2020.10.038","article-title":"Optimal voltage and electrical pulse conditions for electrical ablation to induce immunogenic cell death (ICD)","volume":"94","author":"Go","year":"2021","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.biomaterials.2022.121762_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-bioeng-070909-105249","article-title":"Image-guided interventions: technology review and clinical applications","volume":"12","author":"Cleary","year":"2010","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121762_bib31","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.7150\/thno.32362","article-title":"Strategies for image-guided therapy, surgery, and drug delivery using photoacoustic imaging","volume":"9","author":"Moore","year":"2019","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121762_bib32","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1470-2045(06)70904-4","article-title":"Image-guided radiotherapy: rationale, benefits, and limitations","volume":"7","author":"Dawson","year":"2006","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/acs.bioconjchem.6b00512","article-title":"Inorganic nanoparticles for image-guided therapy","volume":"28","author":"Yoon","year":"2017","journal-title":"Bioconjugate Chem."},{"issue":"42","key":"10.1016\/j.biomaterials.2022.121762_bib34","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1002\/adma.201202433","article-title":"Theranostic probe based on lanthanide\u2010doped nanoparticles for simultaneous in vivo dual\u2010modal imaging and photodynamic therapy","volume":"24","author":"Park","year":"2012","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.biomaterials.2022.121762_bib35","article-title":"Tumor microenvironment targeting nano\u2013bio emulsion for synergistic combinational X\u2010ray PDT with oncolytic bacteria therapy","volume":"9","author":"Park","year":"2020","journal-title":"Adv.healthcare.mater"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121762_bib36","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/nprot.2017.071","article-title":"Single-cell mechanogenetics using monovalent magnetoplasmonic nanoparticles","volume":"12","author":"Kim","year":"2017","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121762_bib38","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/nn900118a","article-title":"Magnetic\u2212 plasmonic core\u2212 shell nanoparticles","volume":"3","author":"Levin","year":"2009","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121762_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"43","key":"10.1016\/j.biomaterials.2022.121762_bib40","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1016\/S0021-9258(18)47090-1","article-title":"Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding","volume":"269","author":"Brown","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121762_bib41","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1073\/pnas.94.12.6523","article-title":"Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides","volume":"94","author":"Rockwell","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0167-4781(99)00140-2","article-title":"A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides","volume":"1489","author":"Levin","year":"2000","journal-title":"Biochim. Biophys. Acta Gene Struct. Expr."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11671-016-1554-y","article-title":"Construction and immunological evaluation of CpG-Au@ HBc virus-like nanoparticles as a potential vaccine","volume":"11","author":"Wang","year":"2016","journal-title":"Nanoscale Res. Lett."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121762_bib44","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ange.201105187","article-title":"Polyvalent immunostimulatory nanoagents with self\u2010assembled CpG oligonucleotide\u2010conjugated gold nanoparticles","volume":"124","author":"Wei","year":"2012","journal-title":"Angew. Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121762_bib45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/smll.201300903","article-title":"Self\u2010assembly of poly\u2010adenine\u2010tailed CpG oligonucleotide\u2010gold nanoparticle nanoconjugates with immunostimulatory activity","volume":"10","author":"Chen","year":"2014","journal-title":"Small"},{"issue":"18","key":"10.1016\/j.biomaterials.2022.121762_bib46","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1016\/j.biomaterials.2012.03.007","article-title":"Core\u2013shell Fe3O4@ NaLuF4: Yb, Er\/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging","volume":"33","author":"Zhu","year":"2012","journal-title":"Biomaterials"},{"issue":"25","key":"10.1016\/j.biomaterials.2022.121762_bib47","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1021\/ja3016582","article-title":"Multifunctional Fe3O4\/TaO x Core\/Shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography","volume":"134","author":"Lee","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2022.121762_bib48","series-title":"Multimodal High-Resolution Imaging of Photoreceptor Precursor Cells Using Gold Nanoparticles, Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XVII","first-page":"112541G","author":"Betzer","year":"2020"},{"key":"10.1016\/j.biomaterials.2022.121762_bib49","first-page":"1","article-title":"Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics","author":"Rennick","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121762_bib50","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1021\/acsnano.5b03184","article-title":"Physical principles of nanoparticle cellular endocytosis","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib51","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3762\/bjnano.5.174","article-title":"Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages","volume":"5","author":"Kuhn","year":"2014","journal-title":"Beilstein J. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/toxsci\/kfp087","article-title":"Mechanisms of quantum dot nanoparticle cellular uptake","volume":"110","author":"Zhang","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.154.1.97","article-title":"CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL","volume":"154","author":"Lanier","year":"1995","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121762_bib54","first-page":"999","article-title":"Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells, Blood","volume":"95","author":"Decker","year":"2000","journal-title":"J. Am. Soc. Hematol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121762_bib55","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00259-010-1687-7","article-title":"In vivo imaging of immune cell trafficking in cancer","volume":"38","author":"Ottobrini","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121762_bib56","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1634\/stemcells.2007-0216","article-title":"Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques","volume":"25","author":"Ebert","year":"2007","journal-title":"Stem Cell."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121762_bib57","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nmat1571","article-title":"An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles","volume":"5","author":"Rabin","year":"2006","journal-title":"Nat. Mater."},{"issue":"31","key":"10.1016\/j.biomaterials.2022.121762_bib58","article-title":"In situ tumor vaccination with nanoparticle co\u2010delivering CpG and STAT3 siRNA to effectively induce whole\u2010body antitumor immune response","volume":"33","author":"Ngamcherdtrakul","year":"2021","journal-title":"Adv Mater"},{"issue":"21","key":"10.1016\/j.biomaterials.2022.121762_bib59","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1016\/j.biomaterials.2010.03.067","article-title":"The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation","volume":"31","author":"Sokolova","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121762_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120988","article-title":"Asynchronous blockade of PD-L1 and CD155 by polymeric nanoparticles inhibits triple-negative breast cancer progression and metastasis","volume":"275","author":"Chen","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121762_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121458","article-title":"Nanoprodrug ratiometrically integrating autophagy inhibitor and genotoxic agent for treatment of triple-negative breast cancer","volume":"283","author":"Wang","year":"2022","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121762_bib62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/CJI.0b013e31820d2a05","article-title":"Anti-tumor activity mediated by CpG: the route of administration is critical","volume":"34","author":"Lou","year":"1997","journal-title":"J. Immunother."},{"issue":"25","key":"10.1016\/j.biomaterials.2022.121762_bib63","article-title":"A dual immunotherapy nanoparticle improves T\u2010cell activation and cancer immunotherapy","volume":"30","author":"Mi","year":"2018","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn5062029","article-title":"Nanoparticle-based immunotherapy for cancer","volume":"9","author":"Shao","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01830-8","article-title":"T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity","volume":"8","author":"Schmid","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121762_bib66","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1002\/ctm2.39","article-title":"T\u2010cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer","volume":"10","author":"He","year":"2020","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","article-title":"CD8+ T\u2010cell memory in tumor immunology and immunotherapy","volume":"211","author":"Klebanoff","year":"2006","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121762_bib68","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ni.3031","article-title":"Molecular regulation of effector and memory T cell differentiation","volume":"15","author":"Chang","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2022.121762_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.01.001","article-title":"Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth","volume":"503","author":"Dai","year":"2021","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121762_bib70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121762_bib71","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.molonc.2015.10.016","article-title":"In situ vaccination: cancer immunotherapy both personalized and off-the-shelf","volume":"9","author":"Hammerich","year":"2015","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4049\/jimmunol.1601145","article-title":"Intratumoral delivery of immunotherapy\u2014act locally, think globally","volume":"198","author":"Aznar","year":"2017","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121762_bib73","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1158\/1078-0432.CCR-13-2116","article-title":"Intratumoral immunization: a new paradigm for cancer therapy","volume":"20","author":"Marabelle","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121762_bib74","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/mt.2016.128","article-title":"Expediting viral therapies for cancers to the clinic","volume":"24","author":"Fong","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2022.121762_bib75","series-title":"A Phase I\/II Study of Pexa-Vec Oncolytic Virus in Combination with Immune Checkpoint Inhibition in Refractory Colorectal Cancer: Safety Report","author":"Morelli","year":"2019"},{"key":"10.1016\/j.biomaterials.2022.121762_bib76","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.omto.2019.06.004","article-title":"Deletion of apoptosis inhibitor F1L in vaccinia virus increases safety and oncolysis for cancer therapy","volume":"14","author":"Pelin","year":"2019","journal-title":"Molecular Therapy-Oncolytics"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-03473-9","article-title":"Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer","volume":"9","author":"Nam","year":"2018","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.biomaterials.2022.121762_bib78","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1158\/0008-5472.CAN-15-2644","article-title":"In situ tumor vaccination by combining local radiation and tumor-specific antibody or immunocytokine treatments","volume":"76","author":"Morris","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121762_bib79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biomaterials.2019.01.015","article-title":"In situ vaccination with biocompatibility controllable immuno-sensitizer inducing antitumor immunity","volume":"197","author":"Shin","year":"2019","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"issue":"28","key":"10.1016\/j.biomaterials.2022.121762_bib81","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1200\/JCO.2010.28.9793","article-title":"In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I\/II study","volume":"28","author":"Brody","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121762_bib82","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1245\/s10434-018-07144-3","article-title":"Evaluating the regulatory immunomodulation effect of irreversible electroporation (IRE) in pancreatic adenocarcinoma","volume":"26","author":"Pandit","year":"2019","journal-title":"Ann. Surg Oncol."},{"issue":"498","key":"10.1016\/j.biomaterials.2022.121762_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw2614","article-title":"Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy","volume":"11","author":"Momin","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121762_bib84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CJI.0000000000000145","article-title":"Synthetic poly (L-glutamic acid)-conjugated CpG exhibits antitumor efficacy with increased retention in tumor and draining lymph nodes after intratumoral injection in a mouse model of melanoma","volume":"40","author":"Ma","year":"1997","journal-title":"J. Immunother."},{"issue":"426","key":"10.1016\/j.biomaterials.2022.121762_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4488","article-title":"Eradication of spontaneous malignancy by local immunotherapy","volume":"10","author":"Sagiv-Barfi","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"26","key":"10.1016\/j.biomaterials.2022.121762_bib86","doi-asserted-by":"crossref","first-page":"21920","DOI":"10.1021\/acsami.8b06633","article-title":"Smaller CpG-conjugated gold nanoconstructs achieve higher targeting specificity of immune activation","volume":"10","author":"Yue","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"37","key":"10.1016\/j.biomaterials.2022.121762_bib87","doi-asserted-by":"crossref","first-page":"31519","DOI":"10.1021\/acsami.7b09583","article-title":"Nanoscale zeolitic imidazolate framework-8 as efficient vehicles for enhanced delivery of CpG oligodeoxynucleotides","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121762_bib88","first-page":"1309","article-title":"Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN, Cancer immunology","volume":"60","author":"Geary","year":"2011","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121762_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063550","article-title":"Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121762_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100021","article-title":"An engineered prussian blue nanoparticles\u2010based nanoimmunotherapy elicits robust and persistent immunological memory in a TH\u2010MYCN neuroblastoma model","volume":"1","author":"Shukla","year":"2021","journal-title":"Adv.NanoBiomed.Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121762_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng.Transl. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121762_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2017.14","article-title":"Towards clinically translatable in vivo nanodiagnostics","volume":"2","author":"Park","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biomaterials.2022.121762_bib93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ebiom.2019.05.036","article-title":"High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity","volume":"44","author":"Ringel-Scaia","year":"2019","journal-title":"EBioMedicine"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:12:20Z","timestamp":1758906740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222004021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":93,"alternative-id":["S0142961222004021"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121762","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Image-guided in situ cancer vaccination with combination of multi-functional nano-adjuvant and an irreversible electroporation technique","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121762"}}